Dr. Joshua G. Cohen

Dr. Joshua G. Cohen, MD, is a widely respected gynecologic oncologist known for his leadership in the treatment of ovarian, endometrial, cervical, and other gynecologic cancers. He serves as the Medical Director of the gynecologic oncology program at City of Hope in Orange County, where he brings his deep clinical expertise and dedication to personalized, evidence-based cancer care. Dr. Cohen received his medical degree from Northwestern University’s Feinberg School of Medicine and completed his residency at the University of California, Los Angeles, followed by fellowship training in gynecologic oncology at the University of Texas MD Anderson Cancer Center. Board-certified in obstetrics and gynecology and gynecologic oncology, he is committed to delivering innovative care with compassion and precision.

Dr. Cohen is highly regarded for his clinical focus on minimally invasive surgical techniques, including robotic-assisted surgery, and fertility-sparing procedures for women with gynecologic malignancies. He is actively involved in clinical research and has led numerous trials exploring novel therapeutic strategies and biomarkers for ovarian and endometrial cancer. His scholarly contributions include authorship on peer-reviewed publications, textbook chapters, and presentations at national and international oncology meetings. He is passionate about integrating the latest advances in precision medicine to improve outcomes while preserving quality of life for his patients.

Beyond his clinical and research achievements, Dr. Cohen is a recognized mentor and advocate for advancing women’s health through education and multidisciplinary collaboration. He is a member of several leading professional societies, including the Society of Gynecologic Oncology and the American Society of Clinical Oncology. Known for his empathetic approach and dedication to patient-centered care, Dr. Cohen is consistently rated highly by patients and colleagues alike. Through his work in both clinical innovation and academic leadership, he continues to elevate the standard of care in gynecologic oncology.